Cargando…

Brg1 restrains the pro-inflammatory properties of ILC3s and modulates intestinal immunity

Group 3 innate lymphoid cells (ILC3s), a subset of the innate lymphoid cells, are abundantly present in the intestine and are crucial regulators of intestinal inflammation. Brg1 (Brahma-related gene 1), a catalytic subunit of the mammalian SWI-SNF-like chromatin-remodeling BAF complex, regulates the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Xinyi, Qiu, Jinxin, Chang, Jiali, Ji, Yan, Yang, Qi, Cui, Guoliang, Sun, Liming, Chai, Qian, Qin, Jun, Qiu, Ju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790751/ https://www.ncbi.nlm.nih.gov/pubmed/32612160 http://dx.doi.org/10.1038/s41385-020-0317-3

Ejemplares similares

Correction: Brg1 restrains the pro-inflammatory properties of ILC3s and modulates intestinal immunity
por: Qi, Xinyi, et al.
Publicado: (2020)

Tissue signals imprint Aiolos expression in ILC2s to modulate type 2 immunity
por: Qiu, Jinxin, et al.
Publicado: (2021)

Inflammatory memory restrains intestinal stem cell regeneration
por: Reddy, Pavan, et al.
Publicado: (2023)

Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease
por: Zheng, Yiyuan, et al.
Publicado: (2022)

ILC2s are the predominant source of intestinal ILC-derived IL-10
por: Bando, Jennifer K., et al.
Publicado: (2019)

Characterization of Rat ILCs Reveals ILC2 as the Dominant Intestinal Subset
por: Abidi, Ahmed, et al.
Publicado: (2020)

Adiponectin restrains ILC2 activation by AMPK-mediated feedback inhibition of IL-33 signaling
por: Wang, Lu, et al.
Publicado: (2020)

Obesity May Provide Pro-ILC3 Development Inflammatory Environment in Asthmatic Children
por: Wu, Yumin, et al.
Publicado: (2018)

Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation
por: Li, Jingyu, et al.
Publicado: (2019)

IL-18/IL-18R Signaling Is Dispensable for ILC Development But Constrains the Growth of ILCP/ILCs
por: Xie, Mengying, et al.
Publicado: (2022)

Drice restrains Diap2-mediated inflammatory signalling and intestinal inflammation
por: Kietz, Christa, et al.
Publicado: (2021)

MKL1 mediates TNF-α induced pro-inflammatory transcription by bridging the crosstalk between BRG1 and WDR5
por: Xu, Wenping, et al.
Publicado: (2019)

Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes
por: Stojanović, Ivana, et al.
Publicado: (2021)

Observation on the efficacy of sublingual immunotherapy with dust mite allergen for perennial allergic rhinitis and the mechanism of action on ILCs with ILC1s and ILC2s and ILC3s
por: Tang, Guangjun, et al.
Publicado: (2022)

Campylobacter infection promotes IFNγ-dependent intestinal pathology via ILC3 to ILC1 conversion
por: Muraoka, Wayne T., et al.
Publicado: (2020)

FXR mediates ILC-intrinsic responses to intestinal inflammation
por: Fu, Ting, et al.
Publicado: (2022)

The BRG1 transcriptional coregulator
por: Trotter, Kevin W., et al.
Publicado: (2008)

Heterogeneity of ILC2s in the Intestine; Homeostasis and Pathology
por: Sunaga, Shogo, et al.
Publicado: (2022)

BRG1: Promoter or Suppressor of Cancer? The Outcome of BRG1’s Interaction with Specific Cellular Pathways
por: Shaykevich, Aaron, et al.
Publicado: (2023)

ILC1s and ILC3s Exhibit Inflammatory Phenotype in Periodontal Ligament of Periodontitis Patients
por: Li, Changyi, et al.
Publicado: (2021)

The Role of BRG1 in Antioxidant and Redox Signaling
por: You, Shilong, et al.
Publicado: (2020)

Increased GM‐CSF‐producing NCR(‐) ILC3s and neutrophils in the intestinal mucosa exacerbate inflammatory bowel disease
por: Chang, Yuna, et al.
Publicado: (2021)

Oncogene-dependent function of BRG1 in hepatocarcinogenesis
por: Wang, Pan, et al.
Publicado: (2020)

HDAC1 and HDAC2 Restrain the Intestinal Inflammatory Response by Regulating Intestinal Epithelial Cell Differentiation
por: Turgeon, Naomie, et al.
Publicado: (2013)

MITF-Independent Pro-Survival Role of BRG1-Containing SWI/SNF Complex in Melanoma Cells
por: Ondrušová, Lubica, et al.
Publicado: (2013)

BRG1 Promotes chromatin remodeling around DNA damage sites
por: Qi, Wenjing, et al.
Publicado: (2018)

ILC1 drive intestinal epithelial and matrix remodelling
por: Jowett, Geraldine M., et al.
Publicado: (2021)

Inflammation triggers ILC3 patrolling of the intestinal barrier
por: Jarade, Angélique, et al.
Publicado: (2022)

The SWI/SNF ATPase BRG1 facilitates multiple pro-tumorigenic gene expression programs in SMARCB1-deficient cancer cells
por: Moe, Kylie C., et al.
Publicado: (2022)

Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness
por: Saladi, Srinivas Vinod, et al.
Publicado: (2010)

Brg1 modulates enhancer activation in mesoderm lineage commitment
por: Alexander, Jeffrey M., et al.
Publicado: (2015)

Fibroblastic reticular cells regulate intestinal inflammation via IL-15-mediated control of group 1 ILCs
por: Gil-Cruz, Cristina, et al.
Publicado: (2016)

ILC
por: Stanitzki, Marcel
Publicado: (2018)

ILC3s protect intestinal stem cells from chemotherapy
por: Eberl, Gérard
Publicado: (2015)

ILC2s—Trailblazers in the Host Response Against Intestinal Helminths
por: Bouchery, Tiffany, et al.
Publicado: (2019)

Comment on “ILC1 drive intestinal epithelial and matrix remodeling”
por: Hariss, Fatima, et al.
Publicado: (2021)

The Tipped Balance of ILC1/ILC2 in Peripheral Blood of Oral Lichen Planus Is Related to Inflammatory Cytokines
por: Wang, Zi-Ming, et al.
Publicado: (2022)

PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions
por: Ercolano, Giuseppe, et al.
Publicado: (2021)

Mechanism of BRG1 silencing in primary cancers
por: Marquez, Stefanie B., et al.
Publicado: (2016)

On the Interaction Between SMARCAL1 and BRG1
por: Bisht, Deepa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p10q2jthb8b1ujmkgpgogrv84p